Cloning of Gallid herpesvirus 3 (Marek's disease virus serotype-2) genome as infectious bacterial artificial chromosomes for analysis of viral gene functions

Journal of Virological Methods

Volumn 158, Issue 1-2, 2009, Pages 11-17

  Petherbridge, Lawrence ^a   Xu, Hongtao ^a   Zhao, Yuguang ^a   Smith, Lorraine P ^a   Simpson, Jennifer ^a   Baigent, Susan ^a   Nair, Venugopal ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Bacterial artificial chromosome; Gallid herpesvirus genome; Marek's disease virus

Indexed keywords

GLYCOPROTEIN E; VIRUS FUSION PROTEIN;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; GENE FUNCTION; MARDIVIRUS; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS GENOME;

ANIMALS; CHICK EMBRYO; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CLONING, MOLECULAR; GENE DELETION; GENETIC VECTORS; GENOME, VIRAL; HERPESVIRUS 3, GALLID; MAREK DISEASE; RECOMBINATION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); GALLID HERPESVIRUS; GALLID HERPESVIRUS 2; GALLID HERPESVIRUS 3; MARDIVIRUS; MAREK'S DISEASE VIRUS SEROTYPE 2 MDV2; MELEAGRID HERPESVIRUS 1;

EID: 64949178560     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.01.009     Document Type: Article

References (44)

1. Adler H., Messerle M., and Koszinowski U.H. Cloning of herpesviral genomes as bacterial artificial chromosomes. Rev. Med. Virol. 13 (2003) 111-121
2. Bacon L.D., Witter R.L., and Fadly A.M. Augmentation of retrovirus-induced lymphoid leukosis by Marek's disease herpesviruses in white leghorn chickens. J. Virol. 63 (1989) 504-512
3. Baigent S.J., Petherbridge L.J., Howes K., Smith L.P., Currie R.J., and Nair V.K. Absolute quantitation of Marek's disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR. J. Virol. Methods 123 (2005) 53-64
4. Baigent S.J., Petherbridge L.J., Smith L.P., Zhao Y., Chesters P.M., and Nair V.K. Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease. J. Gen. Virol. 87 (2006) 769-776
5. Biggs P.M., and Milne B.S. Biological properties of a number of Marek's disease virus isolates. In: Biggs P.M., de The G., and Payne L.N. (Eds). Oncogenesis and Herpesviruses (1972), IARC, Lyon, France 88-94
6. Calnek B.W., Carlisle J.C., Fabricant J., Murthy K.K., and Schat K.A. Comparative pathogenesis studies with oncogenic and non-oncogenic Marek's disease viruses and turkey herpesvirus. Am. J. Vet. Res. 40 (1979) 541-548
7. Calnek B.W., Schat K.A., and Fabricant J. Modification of Marek's disease pathogenesis by in ovo infection or prior vaccination. In: Essex M., Todaro G., and zur Hausen H. (Eds). Viruses in Naturally Occurring Cancers (1980), Cold Spring Harbor, New York 185-197
8. Calnek B.W., Schat K.A., Peckham M.C., and Fabricant J. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease. Avian Dis. 27 (1983) 844-849
9. Cho B.R. Dual virus maturation of both pathogenic and apathogenic Marek's disease herpesvirus (MDHV) in the feather follicles of dually infected chickens. Avian Dis. 21 (1977) 501-507
10. Datsenko K.A., and Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 6640-6645
11. Ellis M.N., Eidson C.S., Brown J., Fletcher O.J., and Kleven S.H. Serological responses to mycoplasma synoviae in chickens infected with virulent or avirulent strains of Marek's disease virus. Poult. Sci. 60 (1981) 1344-1347
12. Friedman A., Shalem-Meilin E., and Heller E.D. Marek's disease vaccines cause temporary B-lymphocyte dysfunction and reduced resistance to infection in chicks. Avian Pathol. 21 (1992) 621-631
13. Griesbeck O., Baird G.S., Campbell R.E., Zacharias D.A., and Tsien R.Y. Reducing the environmental sensitivity of yellow fluorescent protein-mechanisms and applications. J. Biol. Chem. 276 (2001) 29188-29194
14. ICTV, 2006. 00.031.1.03 Mardivirus. In: Búchen-Osmond, C. (Ed.), ICTVdB-The Universal Virus Database, Version 4. Columbia University, New York, USA.
15. Islam A., Harrison B., Cheetham B.F., Mahony T.J., Young P.L., and Walkden-Brown S.W. Differential amplification and quantitation of Marek's disease viruses using real-time polymerase chain reaction. J. Virol. Methods 119 (2004) 103-113
16. Izumiya Y., Jang H.K., Ono M., and Mikami T. A complete genomic DNA sequence of Marek's disease virus type 2, strain HPRS24. Curr. Top. Microbiol. Immunol. 255 (2001) 191-221
17. Jang H.K., Niikura M., Song C.S., and Mikami T. Characterization and expression of the Marek's disease virus serotype 2 glycoprotein E in recombinant baculovirus-infected cells: initial analysis of its DNA sequence and antigenic properties. Virus Res. 48 (1997) 111-123
18. Kawamura H., King J.D.J., and Anderson D.P. A herpesvirus isolated from kidney cell culture of normal turkeys. Avian Dis. 13 (1969) 853-886
19. Lee E.C., Yu D., Martinez de Velasco J., Tessarollo L., Swing D.A., Court D.L., Jenkins N.A., and Copeland N.G. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73 (2001) 56-65
20. Lee L.F., Liu X., and Witter R.L. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens. J. Immunol. 130 (1983) 1003-1006
21. Petherbridge L., Brown A.C., Baigent S.J., Howes K., Sacco M.A., Osterrieder N., and Nair V.K. Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J. Virol. 78 (2004) 13376-13380
22. Petherbridge L., Howes K., Baigent S.J., Sacco M.A., Evans S., Osterrieder N., and Nair V. Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. J. Virol. (2003) 8712-8718
23. Pol J.M.A., Kok G.L., and de Boer G.F. Studies on the oncogenic properties of various Marek's disease virus strains. In: Calnek B.W., and Spencer J.L. (Eds). Proc Int Symp Marek's Dis (1985), American Association of Avian Pathologists, Kennett Square, PA 469-479
24. Ross L.J.N. Recombinant vaccines against Marek's disease. Avian Pathol. 27 (1998) S65-73
25. Salter D.W., Payne W., Kung H.J., Robinson D., Ewert D., Olson W., Crittenden L.B., and Fadly A.M. Enhancement of spontaneous bursal lymphoma frequency by serotype 2 Marek's disease vaccine, SB-1, in transgenic and non-transgenic line 0 white leghorn chickens. Avian Pathol. 28 (1999) 147-154
26. Schat K.A. Isolation of Marek's disease virus: revisited. Avian Pathol. 34 (2005) 91-95
27. Schat K.A., and Calnek B.W. Characterization of an apparently nononcogenic Marek's disease virus. J. Natl. Cancer Inst. 60 (1978) 1075-1082
28. Schumacher D., Tischer B.K., Fuchs W., and Osterrieder N. Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J. Virol. 74 (2000) 11088-11098
29. Schumacher D., Tischer B.K., Reddy S.M., and Osterrieder N. Glycoproteins E and I of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J. Virol. 75 (2001) 11307-11318
30. Tischer B.K., von Einem J., Kaufer B., and Osterrieder N. Two-step Red-mediated recombination for versatile, high-efficiency markerless DNA manipulation in Escherichia coli. BioTechniques 40 (2006) 1-6
31. von Bülow V., Biggs P.M., and Frazier J.A. Characterization of new serotype of Marek's disease herpesvirus. In: de The G., Epstein M.A., and zur Hausen H. (Eds). Oncogenesis and Herpesviruses II vol. 11 (1975), IARC Scientific Publications, Lyon 329-336
32. Warming S., Costantino N., Court D.L., Jenkins N.A., and Copeland N.G. Simple and highly efficient BAC recombineering using galK selection. Nucl. Acids Res. 33 (2005) e36
33. Witter R.L. Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek's Disease virus. Avian Pathol. 11 (1982) 49-62
34. Witter R.L. Influence of serotype and virus strain on synergism between Marek's disease vaccine viruses. Avian Pathol. 21 (1992) 601-614
35. Witter R.L. Marek's disease vaccines - past, present and future (chicken vs. virus - a battle of the centuries). In: Schat K.A., Morgan R.W., Parcells M.S., and Spencer J.L. (Eds). Current Progress on Marek's Disease Research (2001), American Association of Avian Pathologists, Kennett Square, PA 1-9
36. Witter R.L. Protective efficacy of Marek's disease vaccines. Curr. Top. Microbiol. Immunol. 255 (2001) 57-90
37. Witter R.L. Marek's disease: the continuing struggle between pathogen and host. Vet. J. 170 (2005) 149-150
38. Witter R.L., and Lee L.F. Polyvalent Marek's disease vaccines: safety, efficacy and protective synergism in chickens with maternal antibodies. Avian Pathol. 13 (1984) 75-92
39. Witter R.L., Nazerian K., Purchase H.G., and Burgoyne G.H. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am. J. Vet. Res. 31 (1970) 525-538
40. Witter R.L., Sharma J.M., Lee L.F., Opitz H.M., and Henry C.W. Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers. Avian Dis. 28 (1984) 44-60
41. Witter R.L., Silva R.F., and Lee L.F. New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: selected biological and molecular characteristics. Avian Dis. 31 (1987) 829-840
42. Yu D., Ellis H.M., Lee E.C., Jenkins N.A., Copeland N.G., and Court D.L. An efficient recombination system for chromosome engineering in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5978-5983
43. Zelnik V. Marek's disease virus research in the post-sequencing era: new tools for the study of gene functions and virus-host interactions. Avian Pathol. 32 (2003) 323-334
44. Zhao Y., Petherbridge L., Smith L.P., Baigent S., and Nair V. Self-excision of the BAC sequences from the recombinant Marek's disease virus genome increases replication and pathogenicity. Virol. J. 5 (2008) 19